Pancreatic Cancer Research

ResearcherUniversité de PoitiersActive in the last 2 years

Camille Evrard

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3147-1350; OpenAlex author ID A5046077667. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 2 papers

Papers 7

  1. Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer. Co-author DOI 10.1038/s41586-026-10436-4↗
  2. Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective study. Co-author DOI 10.1177/17562848261428776↗
  3. Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study). Co-author DOI 10.1016/j.esmogo.2025.100142↗
  4. Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study. Co-author DOI 10.1093/oncolo/oyaf125↗
  5. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study. Co-author DOI 10.1016/j.dld.2023.03.011↗
  6. Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN). Co-author DOI 10.1016/j.pan.2023.06.010↗
  7. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective obs… Co-author DOI 10.1016/j.ejca.2022.01.040↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Tougeron · 6 shared papers, 2022–2026 · strength 1.20
  2. Nicolas Williet · 5 shared papers, 2022–2026 · strength 0.87
  3. Olivier Bouché · 4 shared papers, 2022–2026 · strength 0.71
  4. Gaël S. Roth · 3 shared papers, 2022–2026 · strength 0.55
  5. Mathias Brügel · 3 shared papers, 2022–2025 · strength 0.51
  6. Anthony Turpin · 3 shared papers, 2022–2026 · strength 0.47
  7. Jean‐Baptiste Bachet · 2 shared papers, 2025–2026 · strength 0.36
  8. Christelle d’Engremont · 2 shared papers, 2022–2026 · strength 0.31
  9. Stéphanie Truant · 2 shared papers, 2022–2023 · strength 0.27
  10. Marie Müller · 1 shared paper, 2025 · strength 0.25
  11. Mircea Chirica · 1 shared paper, 2026 · strength 0.20
  12. Pauline Parent · 1 shared paper, 2026 · strength 0.20
  13. Jean‐Frédéric Blanc · 1 shared paper, 2026 · strength 0.20
  14. Jerome F. Cros · 1 shared paper, 2026 · strength 0.20
  15. Jean‐Yves Scoazec · 1 shared paper, 2026 · strength 0.20
  16. Patrick Mehlen · 1 shared paper, 2026 · strength 0.20
  17. Astrid Lièvre · 1 shared paper, 2026 · strength 0.20
  18. Marine Perrier · 1 shared paper, 2023 · strength 0.16
  19. Raëf Abdallah · 1 shared paper, 2025 · strength 0.16
  20. Alix Portal · 1 shared paper, 2025 · strength 0.16
  21. Franck Bonnetain · 1 shared paper, 2025 · strength 0.16
  22. Anne‐Laure Pointet · 1 shared paper, 2025 · strength 0.16
  23. Laëtitia Dahan · 1 shared paper, 2025 · strength 0.16
  24. Jean–Marc Phelip · 1 shared paper, 2025 · strength 0.16
  25. Émilie Soularue · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.